GSK no quiere entrar en la Marmite...

 

Marmite-owner Unilever makes three bids for GSK consumer goods arm

GlaxoSmithKline has rejected three Unilever offers to buy its consumer goods division, including one worth £50bn.  

GSK said the proposals "fundamentally failed" to reflect the value of the division. 

With a successful bid, Unilever - which owns Marmite, Dove and PG Tips - would add Sensodyne toothpaste and Panadol to its list of  Such a deal would be one of the biggest ever involving London-listed firms.

GSK said in a statement the most recent proposal from Unilever on 20 December contained an offer for £41.7bn in cash and £8.3bn in Unilever shares.

The global healthcare company, which has its headquarters in London, has already been preparing to separate its consumer goods division from its pharmaceutical business in the middle of this year. 

The firm has come under pressure from investors for failing to develop a Covid vaccine.

Unilever said in a statement the GSK consumer arm "would be a strong strategic fit as Unilever continues to reshape its portfolio".

 

The consumer goods giant, which became a fully British company in 2020 after previously being separated between the UK and the Netherlands, also approached Pfizer about the potential deal, since the American pharmaceutical giant owns a 34% stake in GSK's consumer goods business. Ver

Creatividad: PANADOL Guatemala

Ver anteriores PANADOL

Creatividad: PANADOL China

Ver  anteriores Panadol

Creatividad: Panadol Hit The Pain

Glaxo error...

People have been asked to strictly follow doctor’s instructions while administering medicines to children after the UAE Ministry of Health said on Thursday that dosage instructions on a commonly used painkiller for children were wrong. 

The ministry issued the warning after GlaxoSmithKline (GSK) that manufactures Panadol Suspension for infants and children said dosage instructions were wrongly printed. 

However, the ministry said that the medicine would not be withdrawn from the market. Kuwait on Wednesday ordered withdrawal of the medicine from the shelves and also advised doctors not to prescribe the drug until the error was rectified. 

“Dosage instructions on all 13 batches of the medicine available in the UAE have been printed wrongly,” said Dr Amin Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing Sector in UAE Ministry of Health. 

“So, it is important that people follow doctor’s instructions because those will be based on the weight and age of the child,” he said. 

People who buy this medicine over-the-counter, he said, should follow instructions given by the pharmacists. “There is nothing wrong with the medicine but only with the dosage instructions printed on the box,” said Dr Amiri. 

The circular also asked hospitals heads, doctors and pharmacists to take note of the changes. (Más)